DEF 14AThe Ballot
Xeris Biopharma Holdings, Inc. files DEF 14A
Filed Apr 26, 2023 · 3y ago · Accession 0001867096-23-000056
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- XERS
- CIK
- 1867096
- Form type
- DEF 14A
- Filing date
- Apr 26, 2023
- Report date
- Dec 31, 2022
- Document
- a2023proxystatement.htm
- Size
- 1.2 MB